Top Markets
#1 GEKKO GEKKO +50.71%
#2 ADO Protocol ADO Protocol +38.84%
#3 Prom Prom +37.72%
#4 Pons Pons +36.45%
#5 Helium Helium +30.41%
#6 TENDIES TENDIES +28.29%
#7 龙虾 (Lobster) 龙虾 (Lobster) +20.73%
#8 Main Street Yield Main Street Yield +17.48%
#9 o1.exchange o1.exchange +17.20%
#10 OpenGradient OpenGradient +17.05%
Coin of the day
GEKKO GEKKO
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Kolon TissueGene, Inc. Kolon TissueGene, Inc.

Kolon TissueGene, Inc.

950160
Rangering i aksjer #9085
Kolon TissueGene, Inc. is a biopharmaceutical firm specializing in the... Kolon TissueGene, Inc. is a biopharmaceutical firm specializing in the advancement of clinical-stage cell-based treatments for osteoarthritis. Its flagship offering is TG-C, a proprietary platform technology that integrates allogeneic primary cells with genetically engineered counterparts. Established by Kwan H. Lee on June 9, 1999, the enterprise maintains its corporate headquarters in Rockville, Maryland.
Aksjekurs
$12.94
Sist synkronisert: 2026-08-28
Markedsverdi
$1.10B
Endring (1 dag)
-0.16%
Endring (1 år)
-51.50%
Land
US
Handel Kolon TissueGene, Inc. (950160)

Kategori

Healthcare
Aksjeprishistorikk for Kolon TissueGene, Inc. (950160)
Høyeste sluttskurs: $14.96 den 2026-08-01

Laveste sluttskurs: $50.89 den 2017-11-01
Aksjeprishistorikk for Kolon TissueGene, Inc. fra 2017 til 2026
Årlig aksjeprisytelse
År Ytelse
2026 (TTM) -2.28%
2025 232.88%
2024 144.93%
2023 -18.79%
2022 -12.44%
2019 -73.89%
2018 -22.36%
2017 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $542.09 38.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.03K 44.13%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $121.53 -12.70%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $138.18 473.58%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $759.27 7.20%
CH